Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The STRIVE Study: Breast Cancer Screening Cohort for the Development of Assays for Early Cancer Detection

NCT03085888 is registered in ClinicalTrials.gov with GRAIL, Inc. as lead sponsor.

NCT NCT03085888
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03085888 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The STRIVE Study: Breast Cancer Screening Cohort for the Development of Assays for Early Cancer Detection
Lead sponsor
GRAIL, Inc.
Phase
Observational
Overall status
Completed
Start date
February 28, 2017
Completion date
April 1, 2024
Enrollment
99,481 (actual)
Sites
35

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, neoplasms